These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 502719)

  • 41. A study of cefamandole prostatic tissue levels.
    Kaisary AV
    Br J Urol; 1981 Aug; 53(4):336-8. PubMed ID: 7260549
    [No Abstract]   [Full Text] [Related]  

  • 42. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 44. A prospective, randomized, double blind study of preventive cefamandole therapy in patients at high risk for undergoing cholecystectomy.
    Crenshaw CA; Glanges E; Webber CE; McReynolds DB
    Surg Gynecol Obstet; 1981 Oct; 153(4):546-52. PubMed ID: 7025307
    [No Abstract]   [Full Text] [Related]  

  • 45. Cefamandole against Bacteroides fragilis.
    McAllister TA
    Scand J Infect Dis Suppl; 1980; suppl 25():32-6. PubMed ID: 6937949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bacteriological, pharmacological and clinical study of cephazolin].
    Tancrède C; Betourné C
    Nouv Presse Med; 1974 Apr; 3(0):34-7. PubMed ID: 4600178
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical chemotherapy with a new cephalosporin: cephalexin].
    Lamanna A; Gerli P; Periti P; Tomarchio C; Zucconi G
    Riv Ostet Ginecol; 1969 Dec; 24(12):399-411. PubMed ID: 5404220
    [No Abstract]   [Full Text] [Related]  

  • 49. Cefamandole treatment of pulmonary infection caused by gram-negative rods.
    Mandell GL
    Scand J Infect Dis Suppl; 1980; suppl 25():107-11. PubMed ID: 7010535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Investigations on the penetration of cefamandole into spinal fluid (author's transl)].
    Oellers B; Müller O; Fabricius K; Ungemach J
    Infection; 1978; 6(6):294-6. PubMed ID: 730398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [First step to the automatic bacterial sensitivity test (author's transl)].
    Kasahara K; Moriyasu I
    Rinsho Byori; 1979; 27(7):571-5. PubMed ID: 491260
    [No Abstract]   [Full Text] [Related]  

  • 52. Cefamandole--a competitive inhibitor of aldehyde dehydrogenase.
    Freundt KJ; Schreiner E; Christmann-Kleiss U
    Infection; 1985; 13(2):91. PubMed ID: 3997257
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypoprothrombinaemia associated with use of cephamandole.
    O'Donnell D
    Aust N Z J Surg; 1991 Jun; 61(6):471-2. PubMed ID: 2059184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of aldehyde dehydrogenase by a putative metabolite of cefamandole. Re: K.J. Freundt et al. Infection 13 (1985) 91.
    Infection; 1986; 14(1):44-7. PubMed ID: 3957436
    [No Abstract]   [Full Text] [Related]  

  • 55. [Fundamental and clinical studies of cefamandole sodium in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1979 Sep; 32(9):912-29. PubMed ID: 387994
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 57. [Efficiency of cefamandole in the prophylaxis and the treatment of infections of the biliary tract (author's transl)].
    Blairon J; Paulet P; Yourassowski E; Limbosch JM
    Acta Gastroenterol Belg; 1979; 42(9-10):415-26. PubMed ID: 122041
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cephamandole--pharmacokinetic, pharmacodynamic and clinical examinations (author's transl)].
    Car V; Schönwald S; Lenardic A; Gmajnicki B; Falisevac J
    Lijec Vjesn; 1979 Jun; 101(6):371-4. PubMed ID: 502719
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.